HCPCS J-code
J0135: adalimumab
Adalimumab 20 mg (TNF inhibitor) — biosimilar mandate
Code
J0135
Generic
adalimumab
Brands
Humira, Amjevita, Cyltezo, Hadlima, Hyrimoz, Hulio, Yusimry, Idacio, Yuflyma
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- Biosimilar substitution required
- Specialty pharmacy
Frequently asked questions
What is HCPCS J0135?
Adalimumab 20 mg (TNF inhibitor) — biosimilar mandate
Why does insurance commonly deny J0135?
Biosimilar substitution required; Specialty pharmacy.
What brand-name drug uses J0135?
Humira, Amjevita, Cyltezo, Hadlima, Hyrimoz, Hulio, Yusimry, Idacio, Yuflyma.
Related
Appeal a J0135 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com